MHRA publishes latest batch of decisions for complaints about medicines promotion

摘要

Results of five investigations into the way medicines are promoted were published by the Medicines and Healthcare products Regulatory Agency this week.An internet advertisement for NeoClarityn (desloratadine,Schering-Plough) claimed that the antihistamine had no adverse psychomotor effects,although its summary of product characteristics lists psychomotor hyperactivity as a very rare adverse effect.Schering-Plough agreed to withdraw the advertisement.